For a small-molecule blockbuster with thin secondary patent protection, the initial year of multi-source generic competition typically produces an 80-90% price and volume decline
Zepbound mimics the hormones responsible for that signal, and sustains it
Protein helps support muscle mass, energy levels, satiety, and metabolism
Oral Wegovy, launched by Novo Nordisk in January of 2026, is an FDA-approved medication designed to support weight management
Distribution Channel Analysis The hospital pharmacies segment grew at a substantial rate, generating a revenue portion of 57.8% as hospitals are key centers for the diagnosis and management of type 2 diabetes and obesity, often initiating treatment with GLP-1 receptor agonists
SS, AP, TD, and HV: formal analysis